Cardiovascular risk in relation to a newclassification of hypertensive left ventricular geometric abnormalities

Journal of Hypertension

Volumn 33, Issue 4, 2015, Pages 745-754

  De Simone, Giovanni ^a   Izzo, Raffaele ^a   Aurigemma, Gerard P ^b   De Marco, Marina ^a   Rozza, Francesco ^c   Trimarco, Valentina ^a   Stabile, Eugenio ^a   De Luca, Nicola ^a   Trimarco, Bruno ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Cardiovascular outcome; Left ventricular geometry

Indexed keywords

ADULT; ANTHROPOMETRY; ARTERIAL STIFFNESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; FEMALE; GEOMETRY; HEART DEATH; HEART EJECTION FRACTION; HEART INDEX; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL; HEART OUTPUT; HUMAN; HYPERTENSION; LEFT VENTRICULAR GEOMETRIC CLASSIFICATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; VALVULAR HEART DISEASE; VASCULAR RESISTANCE; AGED; CLASSIFICATION; DEATH, SUDDEN, CARDIAC; ECHOGRAPHY; HEART VENTRICLE; HEMODYNAMICS; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; ITALY; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PREVALENCE; REGISTER; RISK FACTOR; STROKE;

ADULT; AGED; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HEMODYNAMICS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROGNOSIS; REGISTRIES; RISK FACTORS; STROKE;

EID: 84938907985     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000477     Document Type: Article

References (33)

1. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19:1550-1558.
2. Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 2004; 43:731-738.
3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-352.
4. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study [see comments]. J Am Coll Cardiol 1995; 25:879-884.
5. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol 1996; 78:197-202.
6. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995; 25:871-878.
7. Pierdomenico SD, Di NM, Pierdomenico AM, Lapenna D, Cuccurullo F. Cardiovascular risk in subjects with left ventricular concentric remodeling at baseline examination: a meta-analysis. J Hum Hypertens 2011; 25:585-591.
8. Gerdts E, Cramariuc D, de Simone G, Wachtell K, Dahlof B, Devereux RB. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr 2008; 9:809-815.
9. de Simone G. Concentric or eccentric hypertrophy: how clinically relevant is the difference? Hypertension 2004; 43:714-715.
10. de Simone G, De Marco M. Cardiovascular risk in subjects with left ventricular concentric remodeling: Does meta-analysis help reconcile inconsistent findings? J Hum Hypertens 2011; 25:575-577.
11. Victor RG, Haley RW, Willett DL, Peshock RM, Vaeth PC, Leonard D, et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 2004; 93:1473-1480.
12. Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study. Circ Cardiovasc Imaging 2010; 3:164-171.
13. Bang CN, Gerdts E, Aurigemma GP, Boman K, de Simone G, Dahlof B, et al. Four group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients. Circ Cardiovasc Imaging 2014; 7:422-429.
14. Izzo R, de Simone G, Chinali M, Iaccarino G, Trimarco V, Rozza F, et al. Insufficient control of blood pressure and incident diabetes. Diabetes Care 2009; 32:845-850.
15. Izzo R, de Simone G, Trimarco V, Gerdts E, Giudice R, Vaccaro O, et al. Hypertensive target organ damage predicts incident diabetes mellitus. Eur Heart J 2013; 34:3419-3426.
16. De Luca N, Izzo R, Iaccarino G, Malini PL, Morisco C, Rozza F, et al. The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis. J Hypertens 2005; 23:1417-1423.
17. de Simone G, Izzo R, Chinali M, De MM, Casalnuovo G, Rozza F, et al. Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension 2010; 56:99-104.
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007; 30 (Suppl 1):S42-S47.
19. Izzo R, de Simone G, Devereux RB, Giudice R, De MM, Cimmino CS, et al. Initial left-ventricular mass predicts probability of uncontrolled blood pressure in arterial hypertension. J Hypertens 2011; 29:803-808.
20. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
21. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
22. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20:1251-1260.
23. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25:1056-1062.
24. de Simone G, Verdecchia P, Pede S, Gorini M, Maggioni AP. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study. Hypertension 2002; 40:470-476.
25. de Simone G,Devereux RB, Ganau A, Hahn RT, Saba PS,MuredduGF, et al. Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography. Am J Cardiol 1996; 78:801-807.
26. de Simone G, Devereux RB, Daniels SR, Mureddu G, Roman MJ, Kimball TR, et al. Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight. Circulation 1997; 95:1837-1843.
27. de Simone G, Schillaci G, Chinali M, Angeli F, Reboldi GP, Verdecchia P. Estimate of white-coat effect and arterial stiffness. J Hypertens 2007; 25:827-831.
28. Chirinos JA, Segers P, de Buyzere ML, Kronmal RA, Raja MW, De BD, et al. Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension 2010; 56:91-98.
29. Bang CN, Gerdts E, Aurigemma GP, Boman K, Dahlof B, Roman MJ, et al. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens 2013; 31:2060-2068.
30. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56:56-64.
31. Carabello BA, Zile MR, Tanaka R, Cooper G. Left ventricular hypertrophy due to volume overload versus pressure overload. Am J Physiol 1992; 263:H1137-H1144.
32. de Simone G, Kitzman DW, Palmieri V, Liu JE, Oberman A, Hopkins PN, et al. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction The HyperGEN study. Am J Hypertens 2004; 17:828-833.
33. de Simone G, Izzo R, Verdecchia P. Are observational studies more informative than randomized controlled trials in hypertension? Pro side of the argument. Hypertension 2013; 62:463-469.